Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy

The utility of Schlafen 11 (SLFN11) expression as a predictive biomarker for platinum‐based chemotherapy has been established for cancers from different histologies. However, the therapeutic relevance of SLFN11 in bladder cancer (BC) is unknown. Here, we examined the clinicopathologic significance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniyama, Daiki, Sakamoto, Naoya, Takashima, Tsuyoshi, Takeda, Masahiko, Pham, Quoc Thang, Ukai, Shoichi, Maruyama, Ryota, Harada, Kenji, Babasaki, Takashi, Sekino, Yohei, Hayashi, Tetsutaro, Sentani, Kazuhiro, Pommier, Yves, Murai, Junko, Yasui, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819307/
https://www.ncbi.nlm.nih.gov/pubmed/34808009
http://dx.doi.org/10.1111/cas.15207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819307/
https://www.ncbi.nlm.nih.gov/pubmed/34808009
http://dx.doi.org/10.1111/cas.15207

Ejemplares similares